ATAD2 | ATPase family, AAA domain containing 2 | Enzymes
| | | | | Mixed |
ATIC | 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
ATP10D | ATPase, class V, type 10D | Enzymes Predicted membrane proteins
| | | | | Mixed |
ATP11A | ATPase, class VI, type 11A | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ATP1A1 | ATPase, Na+/K+ transporting, alpha 1 polypeptide | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP1A3 | ATPase, Na+/K+ transporting, alpha 3 polypeptide | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
ATP2A1 | ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Tissue enriched |
ATP2A3 | ATPase, Ca++ transporting, ubiquitous | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ATP2B1 | ATPase, Ca++ transporting, plasma membrane 1 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ATP2B2 | ATPase, Ca++ transporting, plasma membrane 2 | Enzymes Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ATP2B3 | ATPase, Ca++ transporting, plasma membrane 3 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
ATP2B4 | ATPase, Ca++ transporting, plasma membrane 4 | Enzymes Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP2C1 | ATPase, Ca++ transporting, type 2C, member 1 | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP5B | ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide | Cancer-related genes Enzymes Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
ATP6V1A | ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A | Enzymes Plasma proteins Transporters
| | | | | Expressed in all |
ATP7A | ATPase, Cu++ transporting, alpha polypeptide | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
ATP7B | ATPase, Cu++ transporting, beta polypeptide | Cancer-related genes Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ATP8B1 | ATPase, aminophospholipid transporter, class I, type 8B, member 1 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
ATP9A | ATPase, class II, type 9A | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
ATRX | Alpha thalassemia/mental retardation syndrome X-linked | Cancer-related genes Disease related genes Enzymes Potential drug targets Transcription factors
| | | | | Expressed in all |
ATXN3 | Ataxin 3 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
BAAT | Bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase) | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enriched |
BACE1 | Beta-site APP-cleaving enzyme 1 | Enzymes Predicted membrane proteins Transporters
| | | | | Expressed in all |
BAP1 | BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
BLM | Bloom syndrome, RecQ helicase-like | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enriched |
BLMH | Bleomycin hydrolase | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
BPGM | 2,3-bisphosphoglycerate mutase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
BRIP1 | BRCA1 interacting protein C-terminal helicase 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
C1S | Complement component 1, s subcomponent | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
C2 | Complement component 2 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
CAD | Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
CANT1 | Calcium activated nucleotidase 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
CAPN1 | Calpain 1, (mu/I) large subunit | Enzymes Plasma proteins
| | | | | Expressed in all |
CAPN2 | Calpain 2, (m/II) large subunit | Enzymes Plasma proteins
| | | | | Expressed in all |
CAPN3 | Calpain 3, (p94) | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
CASP1 | Caspase 1, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes
| | | | | Expressed in all |
CASP10 | Caspase 10, apoptosis-related cysteine peptidase | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
CASP3 | Caspase 3, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
CASP6 | Caspase 6, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes
| | | | | Expressed in all |
CASP8 | Caspase 8, apoptosis-related cysteine peptidase | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
CD38 | CD38 molecule | Cancer-related genes CD markers Enzymes
| | | | | Mixed |
CDA | Cytidine deaminase | Enzymes Plasma proteins
| | | | | Tissue enhanced |
CDC14A | Cell division cycle 14A | Enzymes Plasma proteins
| | | | | Mixed |
CDC14B | Cell division cycle 14B | Enzymes Predicted membrane proteins
| | | | | Mixed |
CDC25B | Cell division cycle 25B | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
CDC25C | Cell division cycle 25C | Cancer-related genes Enzymes
| | | | | Tissue enhanced |
CDKN3 | Cyclin-dependent kinase inhibitor 3 | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
CEL | Carboxyl ester lipase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
CELA3A | Chymotrypsin-like elastase family, member 3A | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
CELA3B | Chymotrypsin-like elastase family, member 3B | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |